Self-assembling prodrugs

descriptionPublicationkeyboard_double_arrow_right Article 01 Jan 2017 English Publisher:Royal Society of Chemistry (RSC)Journal:Chem. Soc. Rev., volume 46, pages 6,638-6,663 (issn: 0306-0012, eissn: 1460-4744,

Copyright policy )

Authors: Andrew G. Cheetham; Rami W. Chakroun; Wang Ma; Honggang Cui;

doi: 10.1039/c7cs00521k

pmid: 29019492

pmc: PMC5844511

Self-assembling prodrugs

- Summary
- Subjects
- Metrics

Abstract

Covalent modification of therapeutic compounds is a clinically proven strategy to devise prodrugs with enhanced treatment efficacies. Self-assembly of prodrugs expands the functional space of conventional prodrug design, providing a possible pathway to more effective therapies.

Related Organizations

Johns Hopkins University
United States
Zhengzhou University
China (People's Republic of)
First Affiliated Hospital of Zhengzhou University
China (People's Republic of)

Keywords

Humans, Prodrugs, Nanostructures

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	293
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 1%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 1%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 0.1%